Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results
Shares of Abivax hit the stratosphere Wednesday after the firm unveiled "potentially disruptive" results for its ulcerative colitis drug. The post Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results appeared first on Investor's Business Daily.
Shares of Abivax hit the stratosphere Wednesday after the firm unveiled "potentially disruptive" results for its ulcerative colitis drug.
The post Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
